(SLICHA) UBS (CH) – SLI (CHF) - Ratings and Ratios
Swiss, Stocks, Shares, Equity, Index
Description: SLICHA UBS (CH) – SLI (CHF)
The UBS ETF (CH) – SLI® (CHF) A-dis is an exchange-traded fund that tracks the Morningstar Switzerland TME NR CHF Index, providing investors with exposure to the Swiss equity market. As a Switzerland Equity ETF, it is designed to capture the performance of the Swiss market, making it a suitable investment for those looking to gain exposure to this specific region.
From a technical analysis perspective, the ETF is currently trading at 210.50 CHF, above its 20-day simple moving average (SMA) of 207.90 CHF and its 50-day SMA of 205.05 CHF, indicating a positive short-term trend. The 200-day SMA stands at 203.35 CHF, further confirming the uptrend. The average true range (ATR) is 3.16 CHF, or 1.50%, suggesting moderate volatility. Given the current price is near the upper end of its 52-week range (218.61 CHF high, 180.44 CHF low), we can expect some resistance at the 52-week high. A potential forecast based on technical indicators is that the ETF may continue its upward trend, potentially reaching towards the 52-week high, but may face resistance and potentially consolidate or correct before breaking through this level.
Fundamentally, the Assets Under Management (AUM) are reported as 0.00M CHF, which may indicate either a very small or a newly launched fund, or potentially an error in reporting. Regardless, the ETFs purpose is to track its underlying index, and its performance should closely mirror that of the Morningstar Switzerland TME NR CHF Index. Assuming the ETF is functioning as intended, its fundamental outlook is tied to the overall health and performance of the Swiss equity market.
Combining both technical and fundamental analysis, a potential forecast for the UBS ETF (CH) – SLI® (CHF) A-dis is that it will continue to track the performance of the Swiss equity market, as represented by its underlying index. If the Swiss market continues to perform well, we can expect the ETF to follow suit, potentially pushing towards its 52-week high. However, investors should be cautious of potential volatility and resistance at key levels. A prudent strategy might involve monitoring the ETFs ability to break through resistance levels and adjusting investment decisions accordingly.
Additional Sources for SLICHA ETF
SLICHA ETF Overview
Market Cap in USD | 1,876m |
Category | Switzerland Equity |
IPO / Inception | 2007-09-10 |
SLICHA ETF Ratings
Growth Rating | 48.0 |
Fundamental | - |
Dividend Rating | 46.0 |
Rel. Strength | -10.5 |
Analysts | - |
Fair Price Momentum | 195.18 CHF |
Fair Price DCF | - |
SLICHA Dividends
Dividend Yield 12m | 2.30% |
Yield on Cost 5y | 3.21% |
Annual Growth 5y | 3.50% |
Payout Consistency | 91.0% |
Payout Ratio | % |
SLICHA Growth Ratios
Growth Correlation 3m | 14.4% |
Growth Correlation 12m | 46.2% |
Growth Correlation 5y | 68.5% |
CAGR 5y | 7.08% |
CAGR/Max DD 5y | 0.27 |
Sharpe Ratio 12m | 0.89 |
Alpha | -7.95 |
Beta | 0.623 |
Volatility | 12.11% |
Current Volume | 16k |
Average Volume 20d | 12k |
Stop Loss | 201.3 (-3%) |
As of July 18, 2025, the stock is trading at CHF 207.55 with a total of 16,021 shares traded.
Over the past week, the price has changed by -0.86%, over one month by +1.10%, over three months by +6.90% and over the past year by +2.44%.
Partly, yes. Based on ValueRay´s Analyses, UBS (CH) – SLI (CHF) (SW:SLICHA) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.95 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SLICHA is around 195.18 CHF . This means that SLICHA is currently overvalued and has a potential downside of -5.96%.
UBS (CH) – SLI (CHF) has no consensus analysts rating.
According to our own proprietary Forecast Model, SLICHA UBS (CH) – SLI (CHF) will be worth about 221 in July 2026. The stock is currently trading at 207.55. This means that the stock has a potential upside of +6.47%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 221 | 6.5% |